A Knowledge Hub
At Concord Biotech, we’re dedicated to empowering the professionals with the valuable insights needed to enhance patient care and drive innovation in healthcare.
Concord Biotech in the News
Korea MFDS successfully inspects our API Unit (Dholka)
Concord Biotech’s API Unit 1 (Dholka) has been successfully inspected by Korea MFDS from 18th to 20th February, reinforcing our commitment to global quality and compliance. This achievement highlights our dedication to maintaining the highest international pharmaceutical standards, ensuring that our products continue to meet the stringent regulatory requirements of global markets. As we expand our footprint worldwide, we continue to deliver excellence, innovation, and trust.
